Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07001098 · ClinicalTrials.gov registry record · Phase 2
Amino Acids for Cardiac Surgery Associated AKI
A Phase 2 study, sponsored by Stanford University.
- Not yet
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT07001098: Clinical Trial Phase 2 study, sponsored by Stanford University.
NCT07001098 is a Phase 2 study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07001098, a Phase 2 study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the feasibility of amino acid infusions in pediatric cardiac surgery patients.
Interventions
- DRUG Placebo
- DRUG Amino Acids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-09 |
| Est. Completion | 2026-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07001098
The ClinicalTrials.gov registry entry for NCT07001098 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07001098 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07001098 about?
NCT07001098 is a clinical study titled "Amino Acids for Cardiac Surgery Associated AKI". The purpose of this study is to assess the feasibility of amino acid infusions in pediatric cardiac surgery patients.
What is the current status of trial NCT07001098?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2025-09. Estimated completion is 2026-11.
What interventions are being tested in trial NCT07001098?
The interventions under investigation include: Placebo (DRUG), Amino Acids (DRUG).
Who is sponsoring clinical trial NCT07001098?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.